Purulent lesion(s)

Verify with FDA CVM →

VeDDRA Code: 1193

324 adverse event reports referencing this reaction

324
Total Reports
43
Deaths
1330.0%
Death Rate

Species Most Affected

Dog 270
Cat 48
Horse 4
Guinea Pig 1
Cattle 1

Breeds Most Affected

Domestic Shorthair 31
Retriever - Labrador 30
Crossbred Canine/dog 16
Terrier - Yorkshire 12
Chihuahua 12
Bulldog - French 11
Retriever - Golden 10
Shepherd Dog - German 10
Boxer (German Boxer) 9
Domestic Longhair 8

Associated Drugs

Carprofen 45
Oclacitinib Maleate 33
Maropitant Citrate 26
Gabapentin 25
Prednisone 24
Buprenorphine 21
Cefovecin 18
Diphenhydramine 18
Afoxolaner 17
Tigilanol Tiglate 17
Famotidine 16
Trilostane 16
Enrofloxacin 15
Meloxicam 15
Isoflurane 15
Moxidectin 15
Propofol 14
Bedinvetmab 14
Anti-Il31 Mab Mcs Lot #1283563 12
Robenacoxib 11

Data Summary

Metric Value
Total reports referencing reaction 324
Reports with fatal outcome 43
Case-fatality rate (reported events) 1330.0%
Species observed 5
Breeds observed 20
Drugs associated with reaction 20

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER); reaction term coded under VeDDRA 1193.

Purulent lesion(s) Reaction Insights

The FDA Center for Veterinary Medicine database currently lists 324 adverse event reports that reference Purulent lesion(s) as a reaction term, including 43 reports with a death outcome — a 1330.0% case-fatality figure calculated across only those events where this reaction was coded. The reaction is indexed in the openFDA system under VeDDRA code 1193, the standardized veterinary dictionary used to normalize clinical signs across submitters. Because reports are voluntary and often describe multiple concurrent signs per animal, the volume here reflects reporting intensity rather than true incidence in the broader pet population.

Purulent lesion(s) appears most frequently in reports for Dog (270 reports), Cat (48 reports), Horse (4 reports) — with Dog dominating at 270 entries. Within those species, the breeds most often named alongside this reaction are Domestic Shorthair (31), Retriever - Labrador (30), Crossbred Canine/dog (16). These distributions are influenced both by underlying breed popularity and by how veterinarians and owners code a given clinical sign, so they should be interpreted as a reporting fingerprint rather than a pure susceptibility ranking.

The drugs most commonly co-reported with Purulent lesion(s) are Carprofen (45 reports), Oclacitinib Maleate (33 reports), Maropitant Citrate (26 reports), Gabapentin (25 reports), with Carprofen appearing alongside this reaction in 45 submissions. Co-reporting does not establish that any specific product caused the reaction — FDA CVM data captures temporal association only. The value of these aggregates is in flagging which therapeutic classes appear repeatedly alongside a given clinical sign, so owners and veterinarians can ask targeted questions about medications currently in use.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial